![](/images/2013/post-sep.jpg)
A-S Medication Solutions Announces Strategic Transition
/EIN News/ -- LIBERTYVILLE, Ill., July 01, 2024 (GLOBE NEWSWIRE) -- A-S Medication Solutions (ASM) today announced a strategic transition of its relationship with Triple Aim Consulting, LLC (“TAC”).
For a number of years, ASM has had a consulting agreement with TAC for TAC to assist ASM in managing client accounts. That consulting agreement ended on June 28, 2024.
“ASM is committed to increasing access to medications all across the United States,” said ASM CEO Matt Hoff. “We are proud of our tireless dedication to serving patients in all 50 states.”
Matt Hoff
Chief Executive Officer
(678) 488-7524
https://www.a-smeds.com/testimonials
![](https://ml.globenewswire.com/media/YjU4ODAyOWYtZDgyYS00NGFlLWI1NmEtMWEzN2E5NDAzMDY4LTUwMDEyNTg5Mg==/tiny/A-S-Medication-Solutions.png)
![](https://braincancer.einnews.com/tracking/article.gif?aid=724383239§ion=globenewswire&a=wdmL8rmvmzZaDfQV&i=KUVIqtyyko9-Bb1j)
Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release